Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Forward Therapeutics, Inc. logo — Forward, by Design. Novel chemistry. Proven pathways. Design...

Forward Therapeutics, Inc.

Forward, by Design. Novel chemistry. Proven pathways. Designed for patient impact.

Founded 2022 United States Palm Beach Gardens, United States 12 employees Series A Total: $50.00M

General Information

Company Name Forward Therapeutics, Inc.
Founded Year 2022
Location United States Palm Beach Gardens, United States
Employees 12
Funding Stage Series A
Business Model B2B, B2D
Revenue Model Licensing, Product Sales
Social

BounceWatch is an independent company data service, not affiliated with Forward Therapeutics, Inc.. To contact Forward Therapeutics, Inc., visit forward-tx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Forward Therapeutics, Inc. compare?

A PDF of Forward Therapeutics, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Forward Therapeutics, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Forward Therapeutics, Inc.

Forward Therapeutics, Inc. is a promising United States-based biopharmaceutical company, founded in 2022, that is poised to make significant strides in the treatment of inflammation-driven diseases. With the slogan, "Forward, by Design. Novel chemistry. Proven pathways. Designed for patient impact," the company underscores its commitment to impactful patient outcomes.

Employing a clinical-stage approach, Forward Therapeutics leverages its proprietary SWIFT drug discovery engine. This advanced technology incorporates data analytics to identify and optimize drug targets that are otherwise difficult to tackle, thus expediting the development of oral small molecule therapies.

The company's recent financial milestone includes a substantial $50.00M Series A investment secured on 08 November 2023 from renowned investors—RA Capital Management, OrbiMed, and BVF Partners. This investment indicates strong confidence from the investment community in Forward Therapeutics’ long-term potential and strategic pathway.

Business keywords: Biopharmaceuticals, Clinical-stage, Small Molecule Therapies, Inflammation-driven Diseases, Drug Discovery, Data-driven, Novel Chemistry, SWIFT Drug Discovery Engine, Chronic Inflammatory Disorders, Immune Therapies, Lead Optimization, Screening Assays, Structural Insights

Services & Products

Development of oral therapies
Advancement of drug candidates
Swift™ Discovery Engine

Target Customers

Patients with inflammation-driven diseases Pharmaceutical and healthcare partners Medical and scientific communities

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $50.00M 3
RA Capital Management OrbiMed BVF Partners
RA Capital Management, OrbiMed +1
01 Nov 2023
Seed Undisclosed -
01 Apr 2022

Forward Therapeutics, Inc. Alternatives & Competitors

View All Alternatives
Forward Therapeutics, Inc. vs
Synnovation Therapeutics
Synnovation Therapeutics United States

A precision oncology company focused on small molecule therapies optimized to target key driver mech...

Series A
52 employees
Biotechnology, Health Care
Forward Therapeutics, Inc. vs
Mozart Therapeutics, Inc.
Mozart Therapeutics, Inc. United States

Orchestrating the Immune System

Series A
36 employees
Biotechnology
Forward Therapeutics, Inc. vs
Azome Therapeutics
Azome Therapeutics

Developing selective NLRP3 inflammasome inhibitors for severe inflammatory diseases

Seed
3 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Forward Therapeutics, Inc.

Forward, by Design. Novel chemistry. Proven pathways. Designed for patient impact.
Forward Therapeutics, Inc. was founded in 2022.
Forward Therapeutics, Inc. is headquartered in Palm Beach Gardens, United States.
Forward Therapeutics, Inc. has a B2B and B2D business model. Its revenue comes from Licensing and Product Sales.
Forward Therapeutics, Inc. has approximately 12 employees.
Forward Therapeutics, Inc. has completed 2 funding rounds, raising a total of $50.00M. The latest funding stage is Series A.
Forward Therapeutics, Inc. offers: Development of oral therapies, Advancement of drug candidates, Swift™ Discovery Engine.
Top alternatives and competitors to Forward Therapeutics, Inc. include Synnovation Therapeutics, Mozart Therapeutics, Inc., Azome Therapeutics, Inventiva Pharma, Ajax Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Forward Therapeutics, Inc. and Synnovation Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Forward Therapeutics, Inc., https://bouncewatch.com/company/forward-therapeutics-inc, updated 23 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout